Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2013-04-30
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of the Ultrasound-Guided Retroclavicular Brachial Plexus Block
NCT01605929
Minimum Effective Volume of Local Anesthetic Using Ultrasound for Brachial Plexus Block
NCT01244932
Retroclavicular Versus Supraclavicular Brachial Plexus Block for Hand and Forearm Surgery
NCT02641613
Comparison 1 Plane-1 Injection and 2 Plane-2 Injection Ultrasound-guided Supraclavicular Brachial Plexus Block
NCT02505633
Comparison 1 Plane-2 Injection and 2 Plane-2 Injection Ultrasound-guided Supraclavicular Brachial Plexus Block
NCT02533557
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
120 patients will prospectively be randomized to an USG BP block administered as a single-penetration multiple-injection-technique at one of three different levels: (1) SCL (2) LIC (3) AX. Ropivacaine 0.75% (20 mL) will be used for all blocks prior to surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
USG Supraclavicular block
20 ml of ropivacaine 0,75% is administered to brachial plexus at supraclavicular level.
Ropivacaine
20 ml in total of 0,75% Ropivacaine is administered to each patient in all three arms.
Lateral infraclavicular block
20 ml of ropivacaine 0,75 % is administered to brachialis plexus at lateral infraclavicular level
Ropivacaine
20 ml in total of 0,75% Ropivacaine is administered to each patient in all three arms.
USG Axillaris block
20 ml of ropivacaine 0,75% is administered to plexus brachialis at axillaris level
Ropivacaine
20 ml in total of 0,75% Ropivacaine is administered to each patient in all three arms.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ropivacaine
20 ml in total of 0,75% Ropivacaine is administered to each patient in all three arms.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anaesthesiology class 1-3
* Patients undergoing upper extremity surgery
Exclusion Criteria
* Inability to understand and talk danish
* Allergic to ropivacaine
* Infection at site of surgery
* Neurological dysfunction at site of surgery
* Severe coagulopathy
* Drug and alcohol abuse
* Patients, who can not get a nerve block due to technical difficulty
* Pregnancy or nursing
* Body mass index \>35
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jens Borglum Neimann
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jens Borglum Neimann
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mojgan Vazin, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Anaesthesiology, Bispebjerg hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of anaesthesiology, Bispebjerg Hospital
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Koscielniak-Nielsen ZJ, Frederiksen BS, Rasmussen H, Hesselbjerg L. A comparison of ultrasound-guided supraclavicular and infraclavicular blocks for upper extremity surgery. Acta Anaesthesiol Scand. 2009 May;53(5):620-6. doi: 10.1111/j.1399-6576.2009.01909.x.
Mariano ER, Sandhu NS, Loland VJ, Bishop ML, Madison SJ, Abrams RA, Meunier MJ, Ferguson EJ, Ilfeld BM. A randomized comparison of infraclavicular and supraclavicular continuous peripheral nerve blocks for postoperative analgesia. Reg Anesth Pain Med. 2011 Jan-Feb;36(1):26-31. doi: 10.1097/AAP.0b013e318203069b.
Tran DQ, Munoz L, Zaouter C, Russo G, Finlayson RJ. A prospective, randomized comparison between single- and double-injection, ultrasound-guided supraclavicular brachial plexus block. Reg Anesth Pain Med. 2009 Sep-Oct;34(5):420-4. doi: 10.1097/AAP.0b013e3181ae733a.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-2-2012-055
Identifier Type: OTHER
Identifier Source: secondary_id
BBH-PB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.